Primary Record
Pretomanid
- In stock
- 4,702 g
- Purity
- 99.3 %
- CAS
- 187235-37-6
Compound Identifiers & Properties
- CAS
- 187235-37-6
- PubChem CID
- 456199
- SMILES
- C1[C@@H](COC2=NC(=CN21)[N+](=O)[O-])OCC3=CC=C(C=C3)OC(F)(F)F
- Canonical SMILES
- O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2
Names & Synonyms
- Pretomanid
- PA-824
- 187235-37-6
- pretomanidum
- PA824
- PA 824
- PA824 cpd
- Pretomanid (Standard)
- Pretomanid [USAN:INN]
- 2XOI31YC4N
- PA-824(Pretomanid)
- PRETOMANID [MI]
- RefChem:57158
- UNII-2XOI31YC4N
- MFCD06809939
- AC1L9UFX
- PRETOMANID [INN]
- Pretomanid (USAN/INN)
- C14H12F3N3O5
- PA-824(Pretomanid)?
- PRETOMANID [USAN]
- (S)-PA 824
- Pretomanid(S)-PA 824
- D02AYL
- CHEMBL227875
- PRETOMANID [WHO-DD]
- DTXSID8041163
- MLS006011141
- orb1301077
- SCHEMBL2983011
- (S)-PA 824 (Pretomanid)
- DTXCID6021163
- PRETOMANID [ORANGE BOOK]
- CTK0H8562
- GTPL11172
- KS-00000SKW
- AOB1594
- MMV688755
- ZLHZLMOSPGACSZ-NSHDSACASA-N
- GLXC-02683
- (S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- EX-A1749
- ZINC3821675
- BDBM50363237
- CID456199
- CS1245
- EBC-06939
- HY-10844R
- s1162
- AKOS024464713
- ACN-052207
- C14-H12-F3-N3-O5
- CCG-268145
- CS-3090
- DB05154
- DS-7321
- FP26721
- QC-5184
- NCGC00346682-01
- NCGC00346682-02
- NCGC00346682-10
- AC-25501
- AJ-45733
- DA-66440
- HY-10844
- SMR004702918
- SY105491
- AB0033407
- (6S)-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- A1736
- FT-0673471
- NS00069334
- P2718
- ST24036044
- SW220281-1
- X6951
- J1.347.768J
- A11401
- D10722
- (6S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine
- A855886
- C410767
- SR-05000022748
- Q7118312
- SR-05000022748-1
- BRD-K96671969-001-03-1
- (6S)-2-NITRO-6-{[4-(TRIFLUOROMETHOXY)PHENYL]METHOXY}-5H,6H,7H-IMIDAZO[2,1-B][1,3]OXAZINE
- Z1650127771
- 2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine
- B0084-341037
- (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- (S)-2-NITRO-6-(4-(TRIFLUOROMETHOXY)BENZYLOXY)-6,7-DIHYDRO-5H-IMIDAZO(2,1-B)(1,3)OXAZINE
- (S)-6,7-Dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-5H-imidazo[2,1-b][1,3]oxazine
- (3S)-3-(4-TRIFLUOROMETHOXYBENZYLOXY)-6-NITRO-2H-3,4-DIHYDROIMIDAZO(2,1-B)OXAZINE
- (S)-2-Nitro-5-((4-trifluoromethoxyphenyl)methoxy)-7-oxa-1,3a-diaza-5,6-dihydro-4H-indene
- (S)-2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- 2-Nitro-6alpha-[4-(trifluoromethoxy)benzyloxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- (3S)-8-nitro-3-[[4-(trifluoromethoxy)phenyl]methoxy]-5-oxa-1,7-diazabicyclo[4.3.0]nona-6,8-diene
- (6S)-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-5H,6H,7H-imidazo(2,1-b)(1,3)oxazine
- (6S)-2-Nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro- 5H-imidazo[2,1-b][1,3]oxazine
- (6S)-2-Nitro-6-[4-(trifluoromethoxy)benzyloxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- (6S)-2-Nitro-6-{[4-(trifluoromethoxy)phenyl]methoxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- (S)-2-Nitro-6-[[4-(trifluoromethoxy)benzyl]oxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- {4-[((3S)-6-Nitro(2H,3H,4H-imidazolo[2,1-b]1,3-oxazaperhydroin-3-yloxy))methyl]phenoxy}trifluoromethane
- 5H-Imidazo(2,1-b)(1,3)oxazine, 6,7-dihydro-2-nitro-6-((4-(trifluoromethoxy)phenyl)methoxy)-, (6S)-
- 5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (6S)-
- PA-824|||(6S)-2-Nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine
- Pretomanid; Pretonamid; (S)-2-Nitro-6-((4-(trifluoromethoxy)benzyl)oxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine